Shesternya, P. A., Baranov, A. A., Vinogradova, I. B., Anoshenkova, O. N., Antipova, O. V., Bogdanova, E. A., . . . Lila, A. M. Switching from interleukin-6 receptor inhibitors to the direct interleukin-6 inhibitor olokizumab in patients with rheumatoid arthritis: Efficacy and safety during one year of therapy. IMA-PRESS LLC.
Chicago Style (17th ed.) CitationShesternya, P. A., et al. Switching from Interleukin-6 Receptor Inhibitors to the Direct Interleukin-6 Inhibitor Olokizumab in Patients with Rheumatoid Arthritis: Efficacy and Safety During One Year of Therapy. IMA-PRESS LLC.
MLA (9th ed.) CitationShesternya, P. A., et al. Switching from Interleukin-6 Receptor Inhibitors to the Direct Interleukin-6 Inhibitor Olokizumab in Patients with Rheumatoid Arthritis: Efficacy and Safety During One Year of Therapy. IMA-PRESS LLC.